Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -12,271 | -11,144 | -8,536 | -2,763 |
| Depreciation Amortization | N/A | 402 | 0 | 456 | 705 |
| Other Working Capital | N/A | 1,398 | 644 | -442 | -465 |
| Other Operating Activity | 0 | 423 | 204 | 415 | -3,310 |
| Operating Cash Flow | $N/A | $-10,048 | $-10,296 | $-8,107 | $-5,833 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -129 | -1,582 | -204 | -626 |
| Other Investing Activity | 0 | 5,786 | 0 | -10,921 | 3,627 |
| Investing Cash Flow | $N/A | $5,657 | $-1,582 | $-11,125 | $3,001 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -458 | 0 | -739 | -1,136 |
| Other Financing Activity | 0 | 9,603 | 41 | 23,798 | 14,711 |
| Financing Cash Flow | $N/A | $9,145 | $41 | $23,059 | $13,575 |
| Beginning Cash Position | N/A | 2,428 | 14,347 | 10,520 | 1,616 |
| End Cash Position | N/A | 7,182 | 2,428 | 14,347 | 12,359 |
| Net Cash Flow | $N/A | $4,754 | $-11,919 | $3,827 | $10,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -10,048 | -10,296 | -8,107 | -5,833 |
| Free Cash Flow | 0 | -10,048 | -10,296 | -8,107 | -5,833 |